One approach to understanding the mechanism of immune response (Ir) gene function has been to determine the cell(s) in which the genes are expressed. Experiments with T cells from F1 (responder x nonresponder) guinea pigs (1) and mice (2) , in general, have shown that Ir gene-controlled responses can be initiated by antigen-pulsed responder antigen-presenting cells (APC) but not by antigen-pulsedsnonresponder APC. These findings suggested that one cell type that must express responder Ir gene products is the APC. Furthermore, the interaction between F1 T cell and responder APC could be inhibited by anti-Ia antisera specific for the Ia molecules encoded in the same I subregion in which the Ir gene for the antigen mapped (3, 4) .
Experiments with radiation-induced bone marrow chimeras in general have confirmed the idea that the APC must be of responder genotype to generate Ir gene-controlled responses (5) (6) (7) (8) . In addition, such chimeras have allowed the analysis of the requirements for Ir gene expression at the T-cell level in the absence of allogeneic effects. Chimeric nonresponder T cells which have matured in a responder environment become phenotypic responders, suggesting that the nonresponder T cell is not defective simply because it does not possess the responder Jr gene. In-an effort to learn more about the nature ofthe phenotypic alteration ofnonresponder T cells in the responder environment, we made chimeras of the type B10.A + B10.Q -(B10.A x BIO.Q)Fl. B10 .A mice are responders to poly-(Glu6OAlaTyrl0) (GAT) and nonresponders to poly(Glu'Lys35 Phe9) (GLO). The B1O.Q mice are responders to GLOW and nonresponders to GAT. B10.A + B1O.Q --(BIO.A X BLO.Q)F1 chimeras were primed with GLUT and GAT, and the repertoire of each donor type T-cell population was assayed by killing the other donor type cells with anti-H-2 antisera and complement and adding back to the culture irradiated APC of the killed donor type. Such studies revealed that the chimeric nonresponder T cell becomes a phenotypic responder by learning to recognize responder major histocompatibility complex (MHC) products on the APC. This interaction could be inhibited by anti-Ia antisera specific for the APC, including a monoclonal antibody, but not by anti-Ia antisera specific for the T cell. These experiments provide another argument in support of the idea that the Ia antigens on APC are products of the Ir gene.
MATERIALS AND METHODS Animals. B1O.Q and (B10.A X B10.Q)F1 animals were bred in our own animal colony from stocks originally supplied by J. H. Stimpfling (McLaughlin Research Institute, Great Falls, MT). B10.A mice were purchased from The Jackson Laboratory (Bar Harbor, ME). B1O.T(6R) mice were bred from stocks originally supplied by David Sachs (Transplantation Biology Section, Immunology Branch, National Cancer Institute, Bethesda, MD).
Chimeras. Radiation-induced bone marrow chimeras were made as described (7) . Briefly, (B1O.A X B10.Q)F1 mice were given 925-975 R (0.24-25 C/kg) from a heavily filtered x-ray source and reconstituted on the same day with 107 T cell-depleted bone marrow cells from one or both parents. T cell-depleted bone marrow was obtained by treating donor mice with anti-thymocyte antiserum and cortisone in vivo and rabbit antimouse brain plus guinea pig complement in vitro. The chimeras were used no sooner than 3 months after irradiation. Spleen cells from individual chimeras were H-2 typed before use and all were found to be entirely ofdonor origin. All B10.A + B10.Q -* (B10.A X B1O.Q)Fl chimeras were found to be balanced mixtures ofboth donors (33-67%). Antigens and Immunization. GL46 (originally purchased from Miles-Yeda, Rehovot, Israel) was the generous gift ofAlan Rosenthal (Merck, Rahway, NJ). GAT (lot 6) was purchased from Miles-Yeda. Both antigens were emulsified in complete Freund's adjuvant containing 1 mg of Mycobacterium tuberculosis strain H37Ra (Difco) per ml and administered to mice in Abbreviations: GL4b, poly(Glu56Lys35Phe9); GAT right of I-E, this serum should only recognize determinants on B1O.A cells encoded by the I-At through I-Ek subregions. Chimeric B1O.Q T cells responded to GAT when a source of responder APC (B1O.A spleen cells) was added to the culture (Table 2). Addition of anti-A antiserum, which was capable of reacting only with the B1O.A APC and not the responding B1O.Q T cells, completely inhibited the GAT response as was shown in Table 1 . The GAT response of the chimeric B1O.Q T cells was also inhibited by addition of the A.TH anti-A.TL antiserum. Control experiments showed that the A.TH anti-A.TL antiserum had no effect on the GL4 proliferative response, which requires B1O.Q APC, confirming its specificity for B1O.A Ia determinants. Thus, the data in Tables 1 and 2 suggest that nonresponder T cells maturing in a responder environment become phenotypic responders by acquiring a receptor for responder Ia molecules, and it is this capacity to recognize responder Ia as self which determines the T cell's immune response phenotype.
However, it was possible that other specificities in the anti-H-2 and A.TH anti-A.TL antisera besides anti-Ia antibodies were responsible for the inhibitory effects. For example, it is conceivable that the anti-H-2a antiserum contains anti-T cell receptor antibodies which act on the B1O.Q T cell receptor to inhibit its interaction with responder B1O.A APC in the GAT response (13) . To eliminate this and other possible explanations for the inhibitory effects ofthe antisera, a monoclonal anti-Ia. 17 antibody was used. BlO.T(6R) -* (BlO.A X B1O.Q)F1 chimeras were given T cell-depleted F1 spleen and bone marrow as a source of responder APC and immunized. Lymph node T cells were isolated 8 days later. Any F1 cells surviving this procedure were killed with anti-A antiserum plus complement. The chimeric BlO.T(6R) T cells were found to be GL4 responders and GAT nonresponders (Table 3 ), but they made a substantial proliferative response to GAT when responder B1O.A APC were added in the form of irradiated spleen cells. The GAT response ofthe chimeric BlO.T(6R) T cells was virtually eliminated by the anti-Ia. 17 antibody directed against the responder B1O.A APC whereas the GL4 response, which required H-24 restriction elements, was unaffected. This result unequivocally establishes that it is the Ia antigens on the APC that are being affected by the anti-Ia antisera in these blocking experiments.
In the reciprocal experiment, B1O.A --(B1O.A X BLO.Q)Fl chimeras were given T cell-depleted F1 spleen and bone mar- row cells at immunization as a source of GLbfresponder APC, and any remaining F1 cells were killed with anti-Q antiserum plus complement before assay. Chimeric B1O.A cells thus isolated were assayed and found to respond to GAT but not GL4 (Table 3) . When B1O.Q spleen cells were added as a source of GL4b responder APC, the chimeric B1O.A T cells made a substantial proliferative response to GL4. Addition ofanti-Ia. 17 at a final concentration of 10% inhibited the GAT response almost completely but had little effect on the GL4 response. Thus, the interaction between genotypic B1O.A T cells and B1O.Q APC to generate a GL4 response was not inhibited by an anti-Ia antibody specific for the T cell. The GL4 response was inhibited by anti-Q antiserum, showing again that only antibodies against the responder APC can inhibit the Ir gene-controlled response. DISCUSSION The puzzle in I region control of immune responses has long been to relate the serologically detectable surface structures that are specified by the I region (Ia antigens) to the functions that map to the I region. The observations that I region-controlled T-cell proliferative responses (3) and T cell-dependent in vitro antibody responses (14) could be inhibited by anti-Ia antisera and not by anti-K or anti-D antisera suggested that the Ia antigens might be the Ir gene products. Furthermore, subregion mapping revealed a complete concordance between Ia antigens and Ir genes (3, 4)-that is, Ir gene-controlled responses mapping to I-A were inhibited by anti-Ia antisera with I-A-determined specificities and Ir gene-controlled responses mapping to I-E/C were inhibited by anti-Ia antisera with I-E/C-determined specificities. Finally, in studies with (responder x nonresponder)F, mice, anti-Ia antisera specific for the responder parental haplotype inhibited responses controlled by Ir genes of that haplotype, whereas antisera specific for the nonresponder haplotype had little or no effect (3). This haplotype specificity implied a phenotypic linkage between the Ir gene product and the Ia-bearing molecule at the cell surface, but which cell type was being blocked remained a matter for conjecture.
A direct approach to the question ofwhich cell type is blocked by anti-Ia antisera is the inhibition ofimmune functions involving histoincompatible cells. In such assays, the antisera can be chosen to be selectively directed against either the APC or the responding T cell. This was first attempted by Thomas et aL (15) in the guinea pig. These workers depleted strain 13 lymphocytes ofalloreactivity to strain 2 Ia molecules by culturing strain 13 T cells with strain 2 macrophages in vitro, followed by elimination of the dividing cells by treatment with bromodeoxyuridine and light. The remaining strain 13 T cells could then interact with trinitrophenyl-modified strain 2 macrophages to mount a trinitrophenyl-specific proliferative response. This response was iphibited by antibody against the macrophage (13 anti-2 antisera) but not by antibody against the T cell (2 anti-13 antisera). However, the interpretation of these data was somewhat clouded by the fact that anti-2 alloreactivity was not completely depleted by the negative selection step; therefore, residual allogeneic effects might have been responsible for yielding aberrant results.
Nonetheless, the approach of Thomas et aL (15) appeared to be the best strategy for addressing the question ifone could totally eliminate allogeneic effects. Therefore, we turned to the use of"tetraparental" radiation-induced bone marrow chimeras [PI + P2-* (P1 x P2)Fj], whose lymphocytes had been shown by von Boehmer et aL (16) to be totally devoid of alloreactivity directed against either parental donor haplotype. These chimeras permitted an analysis of the interactions of histoincompatible T cells and APC in reciprocal experiments in the absence of any interference from allogeneic effects. Using this model, we have clearly demonstrated in this paper that anti-Ia antisera act by blocking the APC from initiating a T-cell proliferative response. Anti-Ia sera directed against the T cell are without effect.
The fact that the Ir gene-controlled T-cell response was selectively inhibited by a monoclonal antibody directed at a single determinant on a responder Ia molecule strongly suggests that the Ia molecule is the Ir gene product. Alternatively, it remains a formal possibility that the Ia antigen and the Ir gene product are different structures but are so closely linked at the surface of the APC that binding to the Ia determinant sterically blocks an adjacent Ir gene product. Another possibility is that the anti-Ia antisera might induce a haplotype-specific suppression which acts on any response using that Ia restriction element. These possibilities cannot be ruled out by the techniques used here. Analysis ofI region mutations (17) and possibly DNA cloning of the I region may be required to exclude these less-likely possibilities.
Another important feature of the data presented here is the finding that nonresponder stem cells are not discriminated against in the chimera. We found no evidence for haplotype preference in T-cell maturation in chimeras. In the B1O.A + BlO.Q -+ (B1O.A X BLO.Q)Fj chimeras, if the responder stem cells had been preferentially selected to mature into responder T cells, one might have observed that the mixture of chimeric BLO.A and BlO.Q T cells had made a higher GL4 response than the BLO.A T cells alone. Instead, it was observed that 4 x 105 chimeric B1O.A plus B1O.Q T cells made about the same level of GL4 response as 4 X 1 chimeric nonresponder B1O.A T cells (in Table 1 compare the GL# responses in lines 2 and 4). Similarly, the chimeric BlO.Q T cells, which are genotypically GAT nonresponders, made about the same level of GAT response as the mixture of BLO.A and BLO.Q T cells (Table 1 , compare the GAT response in lines 2 and 8). Even for the non-Ir gene-controlled response to PPD, no haplotype preference was seen. The PPD response of the chimeric B1O.A T cells was blocked about equally well by anti-A and anti-Q antisera as was the PPD response ofthe chimeric BLO.Q T cells. Thus, it appears that ths genotype of the T cell has no predisposing effect upon the selfrestriction repertoire it will develop in the thymus. Finally, the experiments described in this paper examine the mechanism of the phenotypic alteration of the T cell in radiation-induced bone marrow chimeras. Chimeric nonresponder T cells maturing in a responder environment acquired the ability to make Ir gene-controlled responses, but only when the antigen was presented on responder APC. In addition, the proliferative response of the chimeric nonresponder T cells was inhibited by a monoclonal anti-Ia antibody directed against the responder APC. These results suggest that the chimeric nonresponder T cells acquire the ability to respond by developing a receptor specific for responder Ia molecules. The implication is that nonresponder T cells are not genetically defective because they can make Ir gene-controlled responses when they mature in an environment that allows them to recognize responder Ia as self.
